Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 02/09/2008 Portrait of Professor Elke Guenther

    Elke Guenther: inspired by basic research and application-oriented

    The biologist Prof. Dr. Elke Guenther is head of the Department of Electrophysiology at the NMI where her work involves safety pharmacology the development of biosensors and the characterisation of ion channels in the cell membranes in a broad range of different organ systems.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/elke-guenther-inspired-by-basic-research-and-application-oriented
  • Article - 18/08/2008

    Vitamin D reduces mortality risk

    The medical importance of vitamin D calciferol is most likely even higher than suggested by recently published studies. A study which also involves the endocrinologist Bernhard Böhm from Ulm has attracted enormous attention as it suggests that vitamin D deficiency increases mortality.

    https://www.gesundheitsindustrie-bw.de/en/article/news/vitamin-d-reduces-mortality-risk
  • Article - 15/08/2008

    Health research with microsystems

    The NMI Natural and Medical Sciences Institute in Reutlingen organised its biannual MEA conference from 8 to 11 July 2008. More than 200 developers and microelectrode array users from 18 countries came together in Reutlingen to present their latest developments and results.

    https://www.gesundheitsindustrie-bw.de/en/article/news/health-research-with-microsystems
  • Press release - 27/07/2008

    Great knowledge for small people

    The world is full of questions and is sometimes difficult to understand for children. In the lectures delivered at Tübingens Childrens University scientists explain science and mathematics history or business management in a simple way and in relation to everyday life.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/great-knowledge-for-small-people
  • Dossier - 03/07/2008 Normal blood flow in the aorta. MRI also reveals pathological changes and enables the early prognosis of cardiovascular diseases.

    Molecular imaging - a close look inside the human body

    Molecular imaging recognises the functional state of cells and molecules. It visualises biological processes on the cellular and molecular level and is thus able to detect pathological alterations a long time before disease symptoms become apparent. Molecular imaging offers new possibilities for improving diagnosis and enabling more targeted therapies than has previously been possible. Many experts regard molecular imaging as a paradigm shift in…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/molecular-imaging-a-close-look-inside-the-human-body
  • Article - 02/07/2008

    The cancer cells' sweet tooth might be their death sentence

    Cancer cells are dangerous foodies. They metabolise far greater amounts of sugar than healthy cells. Nuclear medicine experts make use of cancer cells craving for sugar since the advent of modern positron emission tomography PET. This has led to an improvement in the quality of cancer treatment.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-cancer-cells-sweet-tooth-might-be-their-death-sentence
  • Article - 30/06/2008

    Safety is paramount

    The new drug screening and safety pharmacology laboratory at NMI Technologie Transfer GmbH NMI TT GmbH in Reutlingen with its standardised and special test systems complies fully with the requirements of safety pharmacology tests.

    https://www.gesundheitsindustrie-bw.de/en/article/news/safety-is-paramount
  • Press release - 06/06/2008

    Collaborative research centre on cardiac diseases to receive further funding

    The German Research Foundation will continue to fund the Transregional Collaborative Research Centre Inflammatory Cardiomyopathy - Molecular Pathogenesis and Therapy for another four years with a total of 10 million euros. The Department of Cardiology of the University Hospital of Tübingen will also become part of the SFB.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/collaborative-research-centre-on-cardiac-diseases-to-receive-further-funding
  • Article - 20/05/2008

    Hugo Hämmerle: At the crossroads between research and industry

    The NMI Natural and Medical Sciences Institute in Reutlingen is a role model for how research findings can be turned into financially sustainable products and services. Prof. Hugo Hämmerle has been a key figure in this success story for over 20 years. In February 2008 he took over as Managing Director of the institute.

    https://www.gesundheitsindustrie-bw.de/en/article/news/hugo-haemmerle-at-the-crossroads-between-research-and-industry
  • Press release - 26/04/2008

    Curetis AG - Compact weapon against tuberculosis

    In conjunction with reference laboratories of the World Health Organization WHO medtech company Curetis AG is developing new technologies and products that identify the pathogens of infectious diseases such as tuberculosis and their resistance. The solutions are impressive.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/curetis-ag-compact-weapon-against-tuberculosis
  • Article - 18/04/2008

    Better bypass with gene therapy?

    Almost half of the veins transplanted to restore blood flow in the heart become clogged again within ten years after surgery. Gene therapy pre-treatment of the vein fragments that prevents the muscle cells from entering the vascular wall might decrease the risk of this happening.

    https://www.gesundheitsindustrie-bw.de/en/article/news/better-bypass-with-gene-therapy
  • Article - 13/04/2008 Liver tumour with vessels during the treatment with microspheres (Photo: Mannheim University Hospital)

    Selective internal radiotherapy

    Since early 2008 the Institute of Clinical Radiology and Nuclear Medicine at Mannheim University Hospital has been offering a new therapy for the treatment of liver cancers selective internal radiotherapy SIRT.

    https://www.gesundheitsindustrie-bw.de/en/article/news/selective-internal-radiotherapy
  • Article - 04/04/2008

    Cell models for human hearts wanted

    A consortium of two universities two applied research institutes and a research-based pharmaceutical company is looking for innovative cellular models of the human heart with the aim of developing better methods for drug testing.

    https://www.gesundheitsindustrie-bw.de/en/article/news/cell-models-for-human-hearts-wanted
  • Article - 21/02/2008

    The inversion of the dorsoventral axis in the separation of Bilataria

    The basic classification of bilateral animals is based on the comparison of their embryonic development and was confirmed in modern molecular phylogeny by the analysis of the relationship of the genes involved. Conserved groups of genes are responsible for the formation of the body axes.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-inversion-of-the-dorsoventral-axis-in-the-separation-of-bilataria
  • Article - 16/02/2008

    Haemochromatosis is a disease of the liver

    Haemochromatosis is not as has been previously assumed a disease of the small intestine but a disease of the liver. Scientists from Heidelberg have shown in the animal model that the disease is caused by a mutated gene influencing hepcidin production.

    https://www.gesundheitsindustrie-bw.de/en/article/news/haemochromatosis-is-a-disease-of-the-liver
  • Article - 10/02/2008

    The only professorship for preclinical imaging in Europe is in Tübingen

    The University of Tübingen opened its new laboratory for Preclinical Imaging and Imaging Technology of the Werner Siemens Foundation. The professorship is the only one in Europe combining preclinical imaging and the development of new imaging technologies.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-only-professorship-for-preclinical-imaging-in-europe-is-in-tuebingen
  • Article - 08/02/2008

    New specialist outpatient clinic offers help for people suffering from haemochromatosis

    A new specialist outpatient clinic at the University Hospital of Ulm is treating haemochromatosis sufferers and is investigating the causes of this disease. Haemochromatosis which as the effect of poisoning the body is one of the most frequent hereditary diseases.

    https://www.gesundheitsindustrie-bw.de/en/article/news/new-specialist-outpatient-clinic-offers-help-for-people-suffering-from-haemochromatosis
  • Press release - 28/01/2008

    Europeans believe biodiversity loss is a problem

    For 93 of Europeans preserving biodiversity is a moral obligation affecting current generations as stewards of nature. European citizens are also aware that their well-being and quality of life depend on biodiversity.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/europeans-believe-biodiversity-loss-is-a-problem
  • Article - 15/01/2008

    Female hearts fibrillate differently

    Gender-specific differences are currently not only a subject of debate for experts but have also raised broad media interest. However there are very few specific investigations that are able to provide a clear answer said Prof. Volker Kühlkamp chief physician in the Department of CardiologyElectrophysiology at the Lake Constance Heart Centre in ConstanceKreuzlingen and specialist in cardiac arrhythmia.

    https://www.gesundheitsindustrie-bw.de/en/article/news/female-hearts-fibrillate-differently
  • Press release - 15/01/2008

    ALVESCO® gains FDA approval for the U.S. market

    The Food and Drug Administration approved Nycomeds ALVESCO ciclesonide Inhalation Aerosol in the United States for the maintenance treatment of asthma and as prophylactic therapy in adult and adolescent patients aged 12 years and older.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/alvesco-gains-fda-approval-for-the-u-s-market
  • Press release - 06/01/2008

    Heart catheter examinations - an elegant method with huge potential

    The method is elegant and cardiologists love it heart catheter examination. The number of catheter examinations carried out has continuously increased over the last few years. In 2005 in Germany an impressive number of 772000 heart catheter examinations were carried out.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/heart-catheter-examinations-an-elegant-method-with-huge-potential
  • Article - 20/12/2007

    Viruses are the major cause of myocardial diseases

    About 500000 people in Germany suffer from dilatative cardiomyopathy DCM. Viral infections are the major cause of this myocardial disease. Its molecular and cellular mechanisms are being investigated in a transregional SFB project at the University of Tübingen.

    https://www.gesundheitsindustrie-bw.de/en/article/news/viruses-are-the-major-cause-of-myocardial-diseases

Page 6 / 6

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search